Raphaël Lepeule
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Raphaël Lepeule has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
N. Houhou
3 shared publicationsP. Yeni
3 shared publicationsV. Joly
3 shared publicationsY. Yazdanpanah
2 shared publications- Bénédicte Lebrun-Vignes
Regional Center of Pharmacovigilance, Department of Medical Pharmacology, Pitié‐Salpêtrière Hospital, AP‐HP Sorbonne Université Paris France
1 shared publication C. Burdet
1 shared publication
Latest Publications
- Open Access
- 31 October 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (11)
Shotgun Metagenomics Versus 16S rDNA Sanger Sequencing for the Diagnosis of Blood Culture-Negative Endocarditis: A Draw?
Although valuable for diagnosing blood culture-negative infective endocarditis, 16S rDNA sequencing and metagenomics on valve/vegetation have never been compared using identical DNA extracts. We compared methods on surgical samples from definite, possible, and rejected infective endocarditis involving culture-negative native valves. Positivity rates were similar, with taxonomic resolution being higher for metagenomics.
- 31 October 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (11)
Open AccessShotgun Metagenomics Versus 16S rDNA Sanger Sequencing for the Diagnosis of Blood Culture-Negative Endocarditis: A Draw?
Although valuable for diagnosing blood culture-negative infective endocarditis, 16S rDNA sequencing and metagenomics on valve/vegetation have never been compared using identical DNA extracts. We compared methods on surgical samples from definite, possible, and rejected infective endocarditis involving culture-negative native valves. Positivity rates were similar, with taxonomic resolution being higher for metagenomics.
- Open Access
- 1 March 2018
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 62 (3)
Dramatic Increase of Amoxicillin-Induced Crystal Nephropathy Found in a Cohort Study of French Pharmacovigilance Centers
An increase in amoxicillin-induced crystal nephropathy (AICN) incidence has been recently suggested. The aims of this study were to investigate the trend of AICN incidence through Paris' regional centers of pharmacovigilance (Paris RCPVs) and better describe this rare adverse drug reaction. Forty-five AICN cases were identified between 1985 and 2016. All cases, except one, were reported since 2010. Amoxicillin (AMX) was administered intravenously (65 [interquartile range {IQR}, 43 to 110] mg/kg of body weight/day) in all patients, either for treating infection ( n = 15) or as surgical prophylaxis ( n = 30). Delay between AMX administration and AICN onset was 1 (IQR, 1 to 3) day; 30, 4, and 11 patients developed KDIGO stage 1, 2, and 3 acute kidney injury, respectively. Delay between AICN onset and kidney function recovery was 4 (IQR, 2 to 6) days. Precipitating factors were identified in only one-third of cases. Twelve patients required intensive care unit admission, and 8 needed renal replacement therapy. Neither chronic kidney disease nor death was observed. We confirmed the recent and dramatic increase of AICN in the Paris RCPVs since 2010. The absence of precipitating factors in the majority of cases and the onset of AICN in apparent routine indications, such as surgical prophylaxis, are alarming and justify a high vigilance from all AMX prescribers.
- 1 March 2018
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 62 (3)
Open AccessDramatic Increase of Amoxicillin-Induced Crystal Nephropathy Found in a Cohort Study of French Pharmacovigilance Centers
An increase in amoxicillin-induced crystal nephropathy (AICN) incidence has been recently suggested. The aims of this study were to investigate the trend of AICN incidence through Paris' regional centers of pharmacovigilance (Paris RCPVs) and better describe this rare adverse drug reaction. Forty-five AICN cases were identified between 1985 and 2016. All cases, except one, were reported since 2010. Amoxicillin (AMX) was administered intravenously (65 [interquartile range {IQR}, 43 to 110] mg/kg of body weight/day) in all patients, either for treating infection ( n = 15) or as surgical prophylaxis ( n = 30). Delay between AMX administration and AICN onset was 1 (IQR, 1 to 3) day; 30, 4, and 11 patients developed KDIGO stage 1, 2, and 3 acute kidney injury, respectively. Delay between AICN onset and kidney function recovery was 4 (IQR, 2 to 6) days. Precipitating factors were identified in only one-third of cases. Twelve patients required intensive care unit admission, and 8 needed renal replacement therapy. Neither chronic kidney disease nor death was observed. We confirmed the recent and dramatic increase of AICN in the Paris RCPVs since 2010. The absence of precipitating factors in the majority of cases and the onset of AICN in apparent routine indications, such as surgical prophylaxis, are alarming and justify a high vigilance from all AMX prescribers.
- 1 November 2015
- Published by Elsevier in Journal Européen des Urgences et de Réanimation
- Vol. 27 (3) , 153-160
Actualité de la rougeole
- 1 November 2015
- Published by Elsevier in Journal Européen des Urgences et de Réanimation
- Vol. 27 (3) , 153-160
Actualité de la rougeole
- 1 May 2015
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 36 (5) , 339-345
Actualité de la rougeole
- 1 May 2015
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 36 (5) , 339-345
Actualité de la rougeole
- Open Access
- 1 April 2014
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 20 (4) , O242-O244
French 2010–2011 measles outbreak in adults: report from a Parisian teaching hospital
- 1 April 2014
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 20 (4) , O242-O244
Open AccessFrench 2010–2011 measles outbreak in adults: report from a Parisian teaching hospital